Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Lung Neoplasms and CD274[original query] |
|---|
| A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes. Journal of thoracic disease 2017 Aug 9 (8): 2560-2571. Li Jin, Chen Yaoqi, Shi Xiaoshun, Le Xiaobing, Feng Fenglan, Chen Jingyi, Zhou Chengzhi, Chen Yusong, Wen Shuai, Zeng Haikang, Chen Allen M, Zhang |
| Correlation of programmed death-ligand 1 expression with gene expression and clinicopathological parameters in Indian patients with non-small cell lung cancer. Lung India : official organ of Indian Chest Society 0 37 (2): 145-150. Kumar Manish, Guleria Bhupesh, Swamy Shivashankar, Soni Sne |
| TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer. Therapeutic advances in medical oncology 2021 8 13 17588359211038477. Li Teng, Wang Han, Xu Jiachen, Li Chengcheng, Zhang Yudong, Wang Guoqiang, Liu Yutao, Cai Shangli, Fang Wenfeng, Li Junling, Wang Zhij |
| Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers. Frontiers in oncology 2021 11 753788. Liang Sheng-Kai, Chien Li-Hsin, Chang Gee-Chen, Tsai Ying-Huang, Su Wu-Chou, Chen Yuh-Min, Huang Ming-Shyan, Lin Hsien-Chih, Fang Wen-Tsen, Hung Hsiao-Han, Jiang Shih-Sheng, Chen Chih-Yi, Chen Kuan-Yu, Chang I-Shou, Hsiung Chao A, Chen Chien-Jen, Yang Pan-Chyr, |
| Treatment Response to Immunotherapy After Crizotinib Resistance in a Patient With Pulmonary Sarcomatoid Carcinoma Harboring MET Exon 14 Skipping Mutation: A Case Report. Clinical Medicine Insights. Oncology 2022 2 16 11795549211067185. Gu Ling, Wei Xiaoying, Zhang Zixiang, Heng W |
| Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade. International immunopharmacology 2023 6 121 110469. Zhaodan Xin, Liting You, Jin Li, Feifei Na, Min Chen, Jiajia Song, Ling Bai, Hao Chen, Jianzhao Zhai, Xiaohan Zhou, Juan Zhou, Binwu Yi |
| Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma. Journal of cancer research and clinical oncology 2023 2 . Moksud Nafeesa, Wagner Marta, Pawe?czyk Konrad, Por?bska Irena, Muszczy?ska-Bernhard Beata, Kowal Aneta, Wi?niewski Andrzej, Kosacka Monika, Ko?czak Julia, Karpi?ski Pawe?, Frydryk Dominik, Andrzejczak Anna, Karabon Lidia, Ku?nierczyk Piotr, Jasek Moni |
| The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility. International immunopharmacology 2023 11 125 (Pt A): 111180. Mohamed I Sakran, Adel I Alalawy, Amnah A Alharbi, Mohamed E El-Hefnawy, Salem M Alzahrani, Ahmed Alfuraydi, Fahad Mohammed Alzuaibr, Nahla S Zidan, Afaf M Elsaid, Eman A Toraih, Rami M Elshaz |
| Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next-Generation Sequencing With Insufficient Tumor Samples. Journal of clinical laboratory analysis 2024 9 e25099. Yi Sun, Xu Zhang, Xinhua Yang, Jiangjun |
| Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non-Small Cell Lung Cancer. JCO precision oncology 2024 8 8 e2300520. Huaying Wang, Lie Lin, Chuqiao Liang, Jiaohui Pang, Jiani C Yin, Junli Zhang, Yang Shao, Chengming Sun, Renhua G |
| NKX2?1 copy number alterations are associated with oncogenic, immunological and prognostic remodeling in non?small cell lung cancer. Oncology letters 2024 5 28 (1): 303. Herdee Gloriane C Luna, Marcelo Severino Imasa, Necy Juat, Katherine V Hernandez, Treah May Sayo, Gloria Cristal-Luna, Sheena Marie Asur-Galang, Mirasol Bellengan, Kent John Duga, Bien Brian Buenaobra, Marvin I De Los Santos, Daniel Medina, Jamirah Samo, Venus Minerva Literal, Sullian Sy-Nav |
| The Prevalence of Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Cancer: An Experience From Tertiary Care Hospital. Cureus 2024 11 16 (10): e72291. Asmita Mehta, Lakshmi Priya V P, Lakshmi Teja, Krishna Pill |
| Identification of immune-related gene signature model for predicting lung cancer survival and response to immunotherapy. Oncology 2024 10 1-25. Wenrong Lin, XiaoJun Cai, YiJin Lin, Weikun Su, Guibin Weng, Lin Chen, Jianming Ding, Yibin C |
- Page last reviewed:Feb 1, 2024
- Content source: